CryoGen - YOUR OPPORTUNITY TO PROLONG LIFE THROUGH THE APPLICATION OF CUTTING-EDGE SCIENCE OF CRYONICS TECHNOLOGY.

The CryoGen project is under the scientific and organizational management of the world - famous cryonics company KrioRus. The CRYO token is a utility token, that gives access to the acquisition of CryoGen services of the CryoStore, which allows you to purchase all available services of the company.

STO/ICO Status

Status
Successful
Symbol
CRYO
Start Date
2017-11-07
End Date
2017-11-21
Hard Cap
100,000,000 USD
Initial Price
1 CRYO = 1 USD
Token Supply
100,000,000
STO/ICO Website Owner of CryoGen?
Claim this listing and publish updates.

Basics

PlatformN/A
TypeN/A
AcceptingOthers
Circulating SupplyN/A
KYCN/A
Restricted AreasN/A
HomepageWebsite URL
White PaperView/Download

Bonus

  • Pre-ICO - 30% discount

About

Medicine of the future

CryoGen will contribute to changing medicine forever. We are in the process of creating the technology for reversible cryopreservation of organs and developing cryobanking for transplantation purposes. Over time, our cryobank will store organs and tissues grown from stem cells or created via 3D bioprinting. Cryopreservation will allow medical specialists more time to use advanced techniques for saving millions of lives.

European development

Cryogen will become the undisputed leader in the cryonics industry in Europe and most likely in Eurasia. Switzerland was chosen as the base of the project’s global headquarters not by chance: euthanasia is allowed there, and, hence, the highest quality cryonics is possible at the moment. Currently, Europe has a very high demand for cryonics, and even now about 25% of the KrioRus contracts are concluded with customers from Western Europe.

Russian development

Cryogen will strengthen KrioRus’s position in Russia with the opening of a new cryocenter in the vicinity of Moscow as well as with the accelerated development of the most affordable and efficient nanocryonics technology. Russian legislation makes it possible to integrate auxiliary services such as DNA preservation, cryobanking of organs, genetic archives, etc.

Next to the stars!

Cryogen has a unique opportunity to become the world’s leader in providing space anabiosis services — we can foresee that our technologies soon will be used for long-duration space travel. And the first step in that direction has already been made.

Team

Valeriya Udalova
Valeriya Udalova
Co-founder and CEO of the Russian company KrioRus
Sergey Evfratov
Sergey Evfratov
Head of Kriorus perfusion lab. Biochemist, a molecular biologist
Yuriy Pichugin
Yuriy Pichugin
Director of Science. PhD. International experience in cryobiology is 40 years.
Elena Serebryannikova
Elena Serebryannikova
A financial adviser to the Cryogen project in Switzerland.
Igor Artyukhov
Igor Artyukhov
Co-Founder and Development Director of KrioRus
Ustin Kolbin
Ustin Kolbin
Director of Communications for Project Cryogen